Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study

Clinical Infectious Diseases

Volumn 44, Issue 2, 2007, Pages 287-294

  Hessol, Nancy A ^a   Kalinowski, Ann ^a   Benning, Lorie ^c   Mullen, Joanne ^c   Young, Mary ^d   Palella, Frank ^e   Anastos, Kathryn ^g   Detels, Roger ^b   Cohen, Mardge H ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f Montefiore Medical Center ^*  (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACCIDENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; EDUCATION; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJURY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEXUALITY; SYMPTOMATOLOGY; UNEMPLOYMENT;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 33846174644     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/510488     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. US Department of Health and Human Services. Atlanta, GA: 2001:1-44.
2. Mocroft A, Vella S, Benfield T, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352:1725-37.
3. Whitman S, Murphy J, Cohen M, Sherer R. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997. Arch Intern Med 2000; 160:365-9.
4. Poundstone K, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS 2001; 15:1115-23.
5. Saraceni V, da Cruz MM, Lauria Lde M, Durovni B. Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy. Braz J Infect Dis 2005; 9:209-15.
6. Vandentorren S, Mercie P, Marimoutou C, et al. Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997. Eur J Epidemiol 2001; 17:7-10.
7. Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 2005; 19:2009-18.
8. Detels R, Muñoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. J Am Med Assoc 1998; 280:1497-1503.
9. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis 2003; 36:1030-8.
10. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 2002; 126:182-90.
11. Smit C, Geskus R, Walker S, et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006; 20:741-9.
12. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 2002; 186:1023-7.
13. Valdez H, Chowdhry TK, Asaad R, et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 2001; 32:1487-93.
14. Bonnet F, Morlat P, Chene G, et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med 2002; 3:195-9.
15. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6:99-106.
16. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology 1998; 9:117-25.
17. Kaslow R, Ostrow D, Detels R, Phair J. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-18.
18. SAS Institute. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute, 1999.
19. Vyrostek SB, Annest JL, Ryan GW. Surveillance for fatal and nonfatal injuries-United States, 2001. MMWR Surveill Summ 2004; 53:1-57.
20. Wang C, Vlahov D, Galai N, et al. The effect of HIV infection on overdose mortality. AIDS 2005; 19:935-42.
21. Smith DK, Gardner LI, Phelps R, et al. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health 2003; 80:676-88.
22. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113:91-8.
23. Centers for Disease Control and Prevention. Web-based injury statistics query and reporting system (WISQARS). Atlanta, GA: National Center for Injury Prevention and Control, Office of Statistics and Programming, 2005.
24. Bacon MC, von Wyl V, Alden C, et al. The women's interagency HIV study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005; 12:1013-19.
25. UNAIDS/WHO. AIDS epidemic update: December 2005. Geneva: UNAIDS/WHO, 2005:1-90.
26. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004; 94:1133-40.